Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

One-Atom Substitution Enables Direct and Continuous Monitoring of Histone Deacylase Activity
Matthes Zessin, Zsófia Kutil, Marat Meleshin, et al.
Biochemistry (2019) Vol. 58, Iss. 48, pp. 4777-4789
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Strategies To Design Selective Histone Deacetylase Inhibitors
Jelena Melesina, Conrad V. Simoben, Lucas Praetorius, et al.
ChemMedChem (2021) Vol. 16, Iss. 9, pp. 1336-1359
Closed Access | Times Cited: 85
Comparative Structure-Based Virtual Screening Utilizing Optimized AlphaFold Model Identifies Selective HDAC11 Inhibitor
Fady Baselious, Sebastian Hilscher, Dina Robaa, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1358-1358
Open Access | Times Cited: 10
Synthesis, Molecular Docking and Biological Characterization of Pyrazine Linked 2-Aminobenzamides as New Class I Selective Histone Deacetylase (HDAC) Inhibitors with Anti-Leukemic Activity
Hany S. Ibrahim, Mohamed Abdelsalam, Yanira Zeyn, et al.
International Journal of Molecular Sciences (2021) Vol. 23, Iss. 1, pp. 369-369
Open Access | Times Cited: 40
Uncovering Robust Delactoylase and Depyruvoylase Activities of HDAC Isoforms
Matthes Zessin, Marat Meleshin, Lucas Praetorius, et al.
ACS Chemical Biology (2022) Vol. 17, Iss. 6, pp. 1364-1375
Closed Access | Times Cited: 23
Development of First-in-Class Dual Sirt2/HDAC6 Inhibitors as Molecular Tools for Dual Inhibition of Tubulin Deacetylation
Laura Sinatra, Anja Vogelmann, F Friedrich, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 21, pp. 14787-14814
Open Access | Times Cited: 16
Hydroxamic acid-modified peptide microarrays for profiling isozyme-selective interactions and inhibition of histone deacetylases
Carlos Moreno–Yruela, Michael Bæk, Adela-Eugenie Vrsanova, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 31
Development of Alkylated Hydrazides as Highly Potent and Selective Class I Histone Deacetylase Inhibitors with T cell Modulatory Properties
Ping Sun, Jing Wang, Khadija Shahed Khan, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 24, pp. 16313-16337
Open Access | Times Cited: 22
Efficacy of a New Selective Indole-based Histone Deacetylase 10 Inhibitor in Targeted Anticancer Therapy
Amer H. Taráwneh, Salah A. Al‐Trawneh, Talha Z. Yesiloglu, et al.
Research Square (Research Square) (2025)
Closed Access
Unlocking the potential of novel Tetrahydro-β-Carboline-based HDAC6 inhibitors for colorectal Cancer therapy: Design, synthesis and biological evaluation
Noreen Hemida, Dalia S. El‐Gamil, Ahmed K. ElHady, et al.
Bioorganic Chemistry (2025), pp. 108454-108454
Closed Access
Novel hydroxamic acid derivative induces apoptosis and constrains autophagy in leukemic cells
Marten A. Fischer, Al‐Hassan M. Mustafa, Kristin Hausmann, et al.
Journal of Advanced Research (2023) Vol. 60, pp. 201-214
Open Access | Times Cited: 9
Mitochondria-targeted inhibitors of the human SIRT3 lysine deacetylase
Kathrin R. Troelsen, Michael Bæk, Alexander L. Nielsen, et al.
RSC Chemical Biology (2021) Vol. 2, Iss. 2, pp. 627-635
Open Access | Times Cited: 19
Revealing chromatin-specific functions of histone deacylases
Carlos Moreno–Yruela, Beat Fierz
Biochemical Society Transactions (2024) Vol. 52, Iss. 1, pp. 353-365
Open Access | Times Cited: 2
Dethioacylation by Sirtuins 1–3: Considerations for Drug Design Using Mechanism-Based Sirtuin Inhibition
Nima Rajabi, Alexander L. Nielsen, Christian A. Olsen
ACS Medicinal Chemistry Letters (2020) Vol. 11, Iss. 10, pp. 1886-1892
Open Access | Times Cited: 20
Utilization of an Optimized AlphaFold Protein Model for Structure-Based Design of a Selective HDAC11 Inhibitor with Anti-neuroblastoma Activity
Fady Baselious, Sebastian Hilscher, Sven Hagemann, et al.
(2024)
Open Access | Times Cited: 2
Utilization of an optimized AlphaFold protein model for structure‐based design of a selective HDAC11 inhibitor with anti‐neuroblastoma activity
Fady Baselious, Sebastian Hilscher, Sven Hagemann, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 10
Open Access | Times Cited: 2
Development of New Inhibitors of HDAC1–3 Enzymes Aided by In Silico Design Strategies
Narges Cheshmazar, Salar Hemmati, Maryam Hamzeh‐Mivehroud, et al.
Journal of Chemical Information and Modeling (2022) Vol. 62, Iss. 10, pp. 2387-2397
Closed Access | Times Cited: 9
Continuous Fluorescent Sirtuin Activity Assay Based on Fatty Acylated Lysines
Matthes Zessin, Marat Meleshin, Sebastian Hilscher, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7416-7416
Open Access | Times Cited: 5
Design and synthesis of bioreductive prodrugs of class I histone deacetylase inhibitors and their biological evaluation in virally transfected acute myeloid leukemia cells
Mohamed Abdelsalam, Mariia Zmyslia, Matthias Schmidt, et al.
Archiv der Pharmazie (2023) Vol. 357, Iss. 2
Open Access | Times Cited: 4
Key structural requirements of benzamide derivatives for histone deacetylase inhibition: design, synthesis and biological evaluation
Narges Cheshmazar, Maryam Hamzeh‐Mivehroud, Salar Hemmati, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 9, pp. 859-872
Closed Access | Times Cited: 1
Characterization of the class IIa histone deacetylases substrate specificity
Zsófia Kutil, Marat Meleshin, Petra Baranová, et al.
The FASEB Journal (2022) Vol. 36, Iss. 5
Closed Access | Times Cited: 6
SART3 associates with a post-splicing complex
Klára Klimešová, Hana Petržílková, Cyril Bařinka, et al.
Journal of Cell Science (2023) Vol. 136, Iss. 2
Open Access | Times Cited: 3
Continuous Sirtuin/HDAC (histone deacetylase) activity assay using thioamides as PET (Photoinduced Electron Transfer)–based fluorescence quencher
Matthes Zessin, Marat Meleshin, Zeljko Simic, et al.
Bioorganic Chemistry (2021) Vol. 117, pp. 105425-105425
Open Access | Times Cited: 7
Novel hydroxamic acid derivative induces apoptosis and constrains autophagy in leukemic cells
Marten A. Fischer, Al‐Hassan M. Mustafa, Kristin Hausmann, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Small Changes Make the Difference for SIRT2: Two Different Binding Modes for 3-Arylmercapto-Acylated Lysine Derivatives
Diana Kalbas, Marat Meleshin, Sandra Liebscher, et al.
Biochemistry (2022) Vol. 61, Iss. 17, pp. 1705-1722
Closed Access | Times Cited: 3
Probing Class I Histone Deacetylases (Hdac) with Proteolysis Targeting Chimera (Protac) for the Development of Highly Potent and Selective Degraders
Hany S. Ibrahim, Menglu Guo, Sebastian Hilscher, et al.
(2024)
Closed Access
Page 1 - Next Page

Scroll to top